Surely women are women? Of course women have specific similarities, but it is their differences that serve to drive home the subtitle of this book, namely, in contemporary menopause management, one size does not fit all! I will return to this subject shortly, but first it is necessary to provide the background information to menopause and its appropriate management.
Let me emphasize one point immediately. Until the late 1990’s, whenever the word menopause came up in some medical circles, it was almost universally equated with another term “Hormone Replacement Therapy (HRT), as if the one could not get along without the other. This implied you could not be fully active or healthy after menopause unless you took hormonal medication. Today, a new philosophy prevails.
A study in the Journal of the American Medical Association (JAMA, April 6,2011)) sheds new light on taking estrogen. Here is what it means to you.
Estrogen versus Estrogen and Progesterone and Uterine Cancer
Like all medications, estrogen is a powerful hormone with benefits and risks that have to be weighed and personalized for each woman. Forty years ago estrogen was so popular and considered so beneficial that almost all women were encouraged to take it from the time of menopause until death. Unfortunately, it was found that estrogen alone can cause cancer of the uterus. Women who have had a hysterectomy and had their uterus removed don’t have this problem.
Then researchers discovered that women who take daily estrogen combined with progesterone for at least 10 days of the month did not get uterine cancer. There were some risks of blood clots and strokes, but overall it was believed that estrogen plus progesterone protected the uterus from uterine cancer and estrogen helped to prevent heart disease. The heart disease part of this changed with more research.
Miami, FL and New York, NY, September 18, 2013 – Noven Pharmaceuticals, Inc., today announced the publication of resultsfrom its two Phase 3 clinical studies in Menopause, the peer-reviewed, scientific journal of The North American Menopause Society. Brisdelle™, paroxetine capsules, 7.5 mg/day, was approved by the United States Food and Drug Administration in June 2013, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to as hot flashes and night sweats.
Dr. Brandon talks with Vibrance Associates, to view the videos click here
Dr. Marianne Brandon, co-author of “Reclaiming Desire” with site Medical Director Dr. Andrew Goldstein, is the author of a new book, Monogamy: The Untold Story. Here is the introduction and excerpt from the book. See Dr. Brandon’s brief bio at the end of the excerpt.As a clinical psychologist and sex therapist, I have devoted many years to helping people open and feel alive, both emotionally and physically. I myself have walked the same path I assist others in traveling every day. It is clear to me that when we are disengaged from any part of ourselves, including our sexuality, our hearts and bodies close in response. When we close, we stop evolving, and we no longer live and love to our fullest potential. Our lives lack creativity and joy, spontaneity and humor. As a culture, we have supported this unfortunate process in each other by ignoring the realities of our sexual instincts.
All material provided on the pages located in the Vibrance Network domains are provided for educational purposes only and are not intended to be a substitute for professional medical advice. Always consult your own physician regarding the applicability of any information on this site with respect to your symptoms or medical condition. Using this site assumes you have read and agreed to the disclaimer.